tiprankstipranks
RayzeBio, Inc. (RYZB)
NASDAQ:RYZB
US Market
Holding RYZB?
Track your performance easily

RayzeBio, Inc. (RYZB) Stock News & Sentiment

27 Followers
RayzeBio, Inc. Completes Merger and Delists from Nasdaq
Premium
Company Announcements
RayzeBio, Inc. Completes Merger and Delists from Nasdaq
9M ago
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
Premium
Market News
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
11M ago
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
Premium
Press Releases
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
11M ago

News Score - Last 7 Days

Neutral
RYZB
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.5 articles
News Sentiment
This Week50%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RYZB’s Media Buzz Sentiment?
2 articles about RYZB were published this week. In an average week, 2.5 articles are published.
    What is RYZB’s weekly average amount of articles?
    In an average week, 2.5 articles about RYZB are published.
      What is RYZB’s News Sentiment?
      50% of articles about RYZB were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        AKROAkero Therapeutics
        KNSAKiniksa Pharmaceuticals
        BIVIBioVie
        PTGXProtagonist Therapeutics
        RVNCRevance Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis